开窗腔内主动脉修复中裸金属与覆膜近端支架固定的比较
本研究基于前瞻性非随机IDE研究数据,比较了使用裸金属固定支架(BMFS)与覆膜固定支架(CFS)进行四分支开窗腔内修复(FEVAR)治疗复杂腹主动脉瘤(CAAA)和IV型胸腹主动脉瘤(TAAA)的临床结局。共纳入147例患者(BMFS组79例,CFS组68例),结果显示两组技术成功率相似(99% vs 100%,p=0.47),30天死亡率均为1%,主要不良事件无差异(15% vs 12%,p=0.59),1年和3年生存率及免于二次干预率均无显著差异。
要点
- BMFS与CFS组技术成功率相似,但CFS组总手术时间和累积空气 karma 显著更低。
- 两组30天死亡率均为1%,主要不良事件无显著差异(15% vs 12%,p=0.59)。
- 1年和3年患者生存率及免于二次干预率在两组间均无显著差异。
核心结论
- 对于CAAA和IV型TAAA的FEVAR,无论是否使用BMFS,技术成功率高、死亡率和主要不良事件低。
- 使用BMFS与不使用BMFS的患者在生存率和免于二次干预率上无差异。
研究设计与样本
- 回顾性分析前瞻性、非随机IDE研究数据,共纳入502例连续患者中的147例(29%)。
- 纳入使用4分支开窗支架(BMFS组79例,CFS组68例)治疗CAAA和IV型TAAA的患者。
- 排除I-III型TAAA及支架设计少于4个开窗或扇形窗的患者。
主要发现
- BMFS组吸烟和外周动脉疾病患病率显著更高(p<0.05),IV型TAAA比例更低。
- 2018年后BMFS设计使用率从88%(64/73)降至20%(15/74)(p<0.001)。
- 技术成功率BMFS组99% vs CFS组100%(p=0.47),CFS组总手术时间和累积空气 karma 显著更低(p<0.05)。
- 总体30天死亡率为1%,两组死亡率和主要不良事件无差异(1% vs 1%,p=1.0;15% vs 12%,p=0.59)。
- 所有患者1年和3年生存率分别为95%±2%和85%±4%,组间无差异(p=0.51);1年免于二次干预率BMFS组88%±3.6% vs CFS组86%±4.6%(p=0.71),3年亦无差异(p=0.55)。
临床怎么用
- 在CAAA和IV型TAAA的FEVAR中,BMFS与CFS的选择不影响技术成功率和主要临床结局。
- CFS可能缩短手术时间并降低辐射剂量,但需结合患者解剖和器械特征个体化选择。
局限性
- 研究为非随机设计,存在选择偏倚可能。
- 仅纳入4分支开窗支架治疗CAAA和IV型TAAA的患者,结论不能推广至其他类型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Fenestrated stent-grafts with proximal bare-metal fixation stent (BMFS) may provide better rotational movement to facilitate vessel catheterization, but novel designs with covered fixation stents (CFSs) have been increasingly utilized with lower profile fabric. This study aimed to evaluate procedural metrics and outcomes of fenestrated endovascular repair (FEVAR) using BMFS and CFS devices. METHODS: Clinical data of 502 consecutive patients enrolled in a prospective, non-randomized investigational device exemption (IDE) study were reviewed. Patients with 4-vessel fenestrated stent-grafts with BMFS or CFS for treatment of complex abdominal aortic aneurysms (CAAAs) and Extent IV thoracoabdominal aortic aneurysms (TAAAs) were included. Patients with Extent I-III TAAAs and stent-grafts designed with <4 fenestrations or scallops were excluded. Endpoints were technical success, radiation exposure, major adverse events (MAEs), patient survival, freedom from secondary interventions, and target artery instability (TAI). RESULTS: There were 147 patients (29%; 85% male, median 75 years old) treated by FEVAR using 4-vessel fenestrated stent-grafts with BMFS in 79 patients or CFS in 68 patients. Patients treated with BMFS designs had significantly (p<0.05) higher prevalence of cigarette smoking and peripheral artery disease and less often had Extent IV TAAAs. Use of BMFS designs decreased from 88% (64/73) to 20% (15/74) after 2018 (p<0.001). Technical success was similar in patients treated with or without BMFS designs (99% vs 100%, p=0.47), but total operating time and cumulative air karma were significantly lower (p<0.05) in patients with CFS designs. Overall 30-day mortality was 1%, with no difference in mortality and MAEs among patients treated with or without BMFS (1% vs 1%, p=1.0 and 15% vs 12%, p=0.59), respectively. Patient survival at 1 and 3 years was 95%±2%, and 85%±4% for all patients with no difference between groups (p=0.51). Freedom from secondary interventions was 88%±3.6% for patients with BMFS and 86%±4.6% for those with CFS at 1 year (p=0.71), with also no difference at 3 years (p=0.55). CONCLUSION: FEVAR for CAAAs and Extent IV TAAAs was performed with high technical success, low mortality, and MAEs, independent of the use of BMFS. There is no difference in patient survival and freedom from secondary interventions in patients treated with or without BMFS.Clinical ImpactOne hundred forty-seven patients were treated with bare-metal fixation-stent (79) or covered fixation stents (68). Technical success was similar (p=.47). Overall 30-day mortality was 1%, with no difference in major adverse events (MAEs; p=.59). At 1- and 3-year, there was no difference in patient survival (p=.51), freedom from secondary intervention (p=.71). In conclusion, FEVAR for CAAAs and Extent IV TAAAs was performed with high technical success, low mortality and MAEs, independent of the use of bare-metal fixation stent.
引用
- Lima GB, Huang Y, Ruiter Kanamori L, et al. Comparison of Bare Metal vs Covered Proximal Stent Fixation During Fenestrated Endovascular Aortic Repair of Complex Abdominal Aortic Aneurysms. J Endovasc Ther. 2025. PMID: 41211656. doi:10.1177/15266028251388749
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。